HEALTHglobal
FDA seeks feedback on voucher program; Study data lift ‘overhang’ on Insmed shares
Single source
Updated 2 hours ago
First seen March 23, 2026 21:05:37Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Industry executives can share their views on the “national priority” program at a June meeting. Elsewhere, Sanofi licensed a T cell engager and Acorda’s former CEO resurfaced at a cell therapy startup.